OMS Grade II Glioma Clinical Trial
Official title:
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma: Multicentric Prospective Study
This is a multicenter prospective study:2 independant cohorts of patients with OMS grade II glioma will be followed during 5 years. - cohort A: patients in first-line treatment (surgery, radiotherapy or chemotherapy) - cohort B: patients with disease simple monitoring. The primary endpoint is to evaluate the impact of tumor and treatments on neurocognitive functions and quality of life, using validate and standard tests.
n/a